


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.89%
+0.30%
-1.43%
+0.96%
+15.95%
TEM
Tempus AI Inc.
$62.36
Strengths

Upgraded on attractively valued
TEM Price Performance
$76.66 (-18.65%)
$103.25 (-39.60%)
$73.23 (-14.84%)
$73.23 (-14.84%)
TEM has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

TEM overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
TEM Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
TEM Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels
What is TEM current stock price?
What are TEM stock strengths?
What is TEM Risk Level?
What is TEM market cap and volume?
What is TEM current Stock IQ?
Should I buy TEM stock right now?
Is TEM a Strong Buy right now?
What does a 'Strong Buy' rating mean for TEM?
What does a 'Strong Sell' rating mean for TEM?
What factors influence TEM's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.89%
+0.30%
-1.43%
+0.96%
+15.95%
TEM
Tempus AI Inc.
Current Price
$62.36
Stock Insights
Strengths

Upgraded on attractively valued

TEM Price Performance
$76.66 (-18.65%)
$103.25 (-39.60%)
$73.23 (-14.84%)
$73.23 (-14.84%)
TEM Analysts Opinion
TEM Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
TEM Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
TEM Street Sentiment is bullish and have positive views on the near-term outlook
TEM has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
TEM Stock IQ
TEM Latest Analysis
TD Cowen Reaffirms Hold Rating on Tempus AI (TEM) Cites the Companys Position to be a Leader. Tempus AI Inc. (NASDAQ:TEM) ranks among the best AI stocks to buy according to analysts. On December 8 TD Cowen reaffirmed its Hold rating on Tempus AI Inc. (NASDAQ:TEM) with an $88 price target. According to TD Cowen analyst Dan Brennan will be joined by a co-analyst in covering the healthcare AI company. The added [….]
Fri Jan 2, 2026
Canaccord Lowers Price Objective On Tempus AI Inc. (TEM). Tempus AI Inc. (NASDAQ:TEM) is among the 12 Best Genomics Stocks to Invest In. TheFly reported on December 22 2025 that Canaccord reduced the price objective for Tempus AI Inc. (NASDAQ:TEM) to $80 from $95. The shares were still rated as a buy by analyst Kyle Mikson. As noted by Canaccord the sector momentum that [….]
Wed Dec 31, 2025
Canaccord Genuity Maintains Tempus AI (TEM) Buy Recommendation. Fintel reports that on December 22 2025 Canaccord Genuity maintained coverage of Tempus AI (NasdaqGS:TEM) with a Buy recommendation. Analyst Price Forecast Suggests 40.19% Upside
Tue Dec 23, 2025
JPMorgan Lowers Tempus AI (TEM) PT to $80 Maintains Neutral Rating. Tempus AI Inc. (NASDAQ:TEM) is one of the best healthcare AI stocks to buy now. On December 15 JPMorgan lowered its price target on Tempus AI Inc. (NASDAQ:TEM) from $85 to $80. The firm maintained its Neutral rating on the shares. This move came as JPMorgan updated its models across the life science tools and [….]
Mon Dec 22, 2025
Tempus AI (TEM) Shares Cross Below 200 DMA. In trading on Wednesday shares of Tempus AI Inc (Symbol: TEM) crossed below their 200 day moving average of $67.03 changing hands as low as $66.66 per share. Tempus AI Inc shares are currently trading off about 1.1% on the day. The chart below shows the one year performance
Wed Dec 17, 2025
JP Morgan Maintains Tempus AI (TEM) Neutral Recommendation. Fintel reports that on December 15 2025 JP Morgan maintained coverage of Tempus AI (NasdaqGS:TEM) with a Neutral recommendation. Analyst Price Forecast Suggests 32.59% Upside
Tue Dec 16, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.